Maram Alenzi

Dr. Maram Alenzi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2024 in Journal of Hepatology
Verified
Journal Article
Open access
PHPinzhu Huang
Pinzhu Huang
GWGuangyan Wei
Guangyan Wei
JKJesse D. Kirkpatrick
Jesse D. Kirkpatrick
YLYi Lin
Yi Lin
LTLi Tan
Li Tan
YPYury V. Popov
Yury V. Popov
Cholangiocarcinoma (CCA) is a dreaded complication of primary sclerosing cholangitis (PSC) that is difficult to diagnose and associated with high mortality. A lack of animal models of CCA recapitulating the hepatic microenvironment of sclerosing cholangitis has hindered the development of novel treatments. Herein, we sought to develop a mouse model of PSC-associated CCA. Ten-week-old Mdr2-/- mice with congenital PSC-like disease, and healthy wild-type littermates were subjected to either modified retrograde biliary instillation or hydrodynamic tail vein injection of a sleeping beauty transposon-transposase plasmid system with activated AKT (myr-AKT) and Yap (YapS127A) proto-oncogenes (SB AKT/YAP1). The role of TGFβ was interrogated via ALK5 inhibitor (SB-525334) administration. Tumor phenotype, burden and desmoplastic reaction were analyzed histologically and via RNA sequencing. While SB AKT/YAP1 plasmids administered via retrograde biliary injection caused tumors in Mdr2-/-, only 26.67% (4/15) of these tumors were CCA. Alternatively, hydrodynamic tail vein injection of SB AKT/YAP1 resulted in robust tumorigenesis in all fibrotic Mdr2-/- mice with high CCA burden compared to healthy mice. Tumors phenotypically resembled human CCA, expressed multiple CCA (but not hepatocellular carcinoma) markers, and exhibited a profound desmoplastic reaction. RNA sequencing analysis revealed profound transcriptional changes in CCA evolving in a PSC-like context, with specific alterations in multiple immune pathways. Pharmacological TGFβ inhibition led to enhanced immune cell tumor infiltration, reduced tumor burden and suppressed desmoplastic collagen accumulation compared to placebo. We established a new high-fidelity cholangiocarcinoma model in mice, termed SB CCA.Mdr2-/-, which recapitulates the increased susceptibility to CCA in the setting of biliary injury and fibrosis observed in PSC. Through transcriptomics and pharmacological studies, we show dysregulation of multiple immune pathways and TGFβ signaling as potential drivers of CCA in a PSC-like microenvironment. Animal models for primary sclerosing cholangitis (PSC)-related cholangiocarcinoma (PSC-CCA) are lacking. Thus, we have developed and characterized a new mouse model of PSC-CCA, termed SB CCA.Mdr2-/-, which features reliable tumor induction on a PSC-like background of biliary injury and fibrosis. Global gene expression alterations were identified and standardized tools, including automated whole slide image analysis methodology for tumor burden and feature analysis, were established to enable systematic research into PSC-CCA biology and formal preclinical drug testing.

1 January 2024 in Therapeutic Advances in Gastroenterology
Verified
Journal Article
Open access
MAMaram Alenzi
Maram Alenzi
TSTamar Schildkraut
Tamar Schildkraut
IHImogen Hartley
Imogen Hartley
SBSarit Badiani
Sarit Badiani
NDNik Sheng Ding
Nik Sheng Ding
Jonathan SegalJonathan Segal
Jonathan Segal
Restorative proctocolectomy with ileal pouch-anal anastomosis is a treatment option for patients with refractory ulcerative colitis. Pouchitis is the most common complication, representing a spectrum of diseases ranging from acute antibiotic-responsive type to chronic antibiotic-refractory. Early accurate diagnosis using a combined assessment of symptoms, endoscopy and histology is important for both treatment and prognostication. Most patients respond well to antibiotic therapy; however, management of chronic antibiotic-refractory pouchitis remains a challenge, and treatment options are based on small studies. Pouchitis is thought to be driven by the interaction between genetics, the immune system and the environment but as yet a causal relationship has yet to be identified. Further longitudinal assessment of the pouch integrating new technologies may help us understand the factors driving pouchitis. This review outlines the currently understood risk factors and aetiology of pouchitis.

16 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
ESEman Al Sulais
Eman Al Sulais
TATurki AlAmeel
Turki AlAmeel
MAMaram Alenzi
Maram Alenzi
MSMohammad Shehab
Mohammad Shehab
AAAbdulelah Almutairdi
Abdulelah Almutairdi
BABadr F Al-Bawardy
Badr F Al-Bawardy
Patients with inflammatory bowel disease (IBD), including ulcerative colitis and colonic Crohn’s disease, are at an increased risk of developing colonic dysplasia and neoplasia. Multiple risk factors have been identified that increase the risk of colonic neoplasia in IBD, including but not limited to underlying disease extent, severity, duration, and concomitant primary sclerosing cholangitis. The overall risk of colonic neoplasia in IBD is decreasing but surveillance is still warranted in patients with high-risk features. In this review, we will discuss the epidemiology, pathogenesis, risk factors, approach to surveillance, and management of colonic neoplasia in IBD.

1 June 2024 in ACG Case Reports Journal
Verified
Journal Article
Open access
MAMaram Alenzi
Maram Alenzi
IRIyiad Alabdul Razzak
Iyiad Alabdul Razzak
DEDarren Evanchuk
Darren Evanchuk
SKSvetlana Kondratiev
Svetlana Kondratiev
SMSyed Kashif Mahmood
Syed Kashif Mahmood
MTManish Tandon
Manish Tandon
Resent a rare case of PG-DLBCL diagnosed with H. pylori. An 82-year-old man presented to clinic with complaints of worsening epigastric pain. He underwent an endoscopy which revealed 1 large nonbleeding gastric ulcer. Histopathological and immunohistochemical analysis confirmed PG-DLBCL. He was started on H. pylori eradication (HPE) and subsequently completed 6 cycles of R-mini-CHOP chemotherapy. Since then, the patient maintained clinical and radiological remission for more than a year without recurrence. PG-DLBCL is an aggressive Non-hodgkin lymphoma (NHL) that usually presents late. It has been shown that HPE without chemotherapy in DLBCL codiagnosed with H. pylori is not an effective strategy. Thus, the standard of care for patients would be HPE and chemotherapy as in our patient. More research is needed to better understand association between H. pylori and DLBCL....

1 July 2026 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
TWTaixuan Wan
Taixuan Wan
YSYunxing Shi
Yunxing Shi
YZYihang Zhou
Yihang Zhou
HZHaoqi Zheng
Haoqi Zheng
HXHao Xie
Hao Xie
LHLiang Huang
Liang Huang

21 May 2025 in Gastro Hep Advances
Verified
Journal Article
Open access
MAMaram Alenzi
Maram Alenzi
DDDimo Dimitrov
Dimo Dimitrov
IAIyiad AlAbdul-Razzak
Iyiad AlAbdul-Razzak
NANawaf Alhazmi
Nawaf Alhazmi
EVEduardo Vega
Eduardo Vega
SMSyed Kashif Mahmood
Syed Kashif Mahmood
Bouveret syndrome, a rare complication of cholelithiasis (1%–3%), leads to high mortality (12%–30%). It occurs when a gallstone passes through a cholecystoduodenal fistula, causing gastric outlet obstruction. We report a 66-year-old woman with abdominal pain, nausea, and vomiting. Imaging showed acute cholecystitis, pneumobilia, cholecystoduodenal fistula, and a 5-cm gallstone obstructing the gastric outlet. Initial treatment with antibiotics and endoscopic lithotripsy relieved the obstruction but did not remove the entire stone. Surgery with open gastrotomy successfully extracted the stones, and follow-up confirmed fistula closure. This case highlights the need for early diagnosis and a multidisciplinary treatment approach.